Lewis Bender
Vorstandsvorsitzender bei INTENSITY THERAPEUTICS, INC.
Vermögen: 8 Mio $ am 30.04.2024
Aktive Positionen von Lewis Bender
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Vorsitzender | 01.04.2012 | - |
| Vorstandsvorsitzender | 01.04.2012 | - | |
| Gründer | 01.01.2012 | - | |
| Direktor/Vorstandsmitglied | 01.01.2012 | - | |
| Präsident | 01.01.2012 | - |
Karriereverlauf von Lewis Bender
Ehemalige bekannte Positionen von Lewis Bender
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTERLEUKIN GENETICS, INC | Direktor/Vorstandsmitglied | 17.02.2011 | 23.08.2012 |
| Vorstandsvorsitzender | 22.01.2008 | 23.08.2012 | |
| EMISPHERE TECHNOLOGIES, INC. | Vorstandsvorsitzender | 01.01.1993 | 01.12.2007 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 | 01.12.2007 | |
| Präsident | 01.01.1993 | 01.12.2007 |
Ausbildung von Lewis Bender
| University of Pennsylvania | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
- Börse
- Insiders
- Lewis Bender
- Erfahrung
